Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127061302 | 12706130 | 2 | F | 20160428 | 20160901 | 20160901 | PER | US-JAZZ-2016-US-008099 | JAZZ | 0.00 | F | Y | 0.00000 | 20160901 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127061302 | 12706130 | 1 | PS | XYREM | SODIUM OXYBATE | 1 | Oral | 4.5 G, BID | 21196 | 4.5 | G | ORAL SOLUTION | |||||||
| 127061302 | 12706130 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | DOSE ADJUSTMENTS | 21196 | ORAL SOLUTION | |||||||||
| 127061302 | 12706130 | 3 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 6 G, BID | 21196 | 6 | G | ORAL SOLUTION | |||||||
| 127061302 | 12706130 | 4 | SS | PRAVASTATIN. | PRAVASTATIN | 1 | UNK | 0 | |||||||||||
| 127061302 | 12706130 | 5 | C | DEPAKOTE ER | DIVALPROEX SODIUM | 1 | U | 0 | |||||||||||
| 127061302 | 12706130 | 6 | C | CINNAMON. | CINNAMON | 1 | U | 0 | |||||||||||
| 127061302 | 12706130 | 7 | C | GARLIC. | GARLIC | 1 | U | 0 | |||||||||||
| 127061302 | 12706130 | 8 | C | GUAIFENESIN. | GUAIFENESIN | 1 | U | 0 | |||||||||||
| 127061302 | 12706130 | 9 | C | LOSARTAN AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDELOSARTAN POTASSIUM | 1 | U | 0 | |||||||||||
| 127061302 | 12706130 | 10 | C | OXCARBAZEPINE. | OXCARBAZEPINE | 1 | U | 0 | |||||||||||
| 127061302 | 12706130 | 11 | C | STRATTERA | ATOMOXETINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 127061302 | 12706130 | 12 | C | Calcium + vitamin d | CALCIUMVITAMIN D | 1 | U | 0 | |||||||||||
| 127061302 | 12706130 | 13 | C | OXAZEPAM. | OXAZEPAM | 1 | U | 0 | |||||||||||
| 127061302 | 12706130 | 14 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | U | 0 | |||||||||||
| 127061302 | 12706130 | 15 | C | LAMOTRIGINE. | LAMOTRIGINE | 1 | U | 0 | |||||||||||
| 127061302 | 12706130 | 16 | C | LOSARTAN POTASSIUM. | LOSARTAN POTASSIUM | 1 | U | 0 | |||||||||||
| 127061302 | 12706130 | 17 | C | ZYPREXA | OLANZAPINE | 1 | U | 0 | |||||||||||
| 127061302 | 12706130 | 18 | C | Desipramine | DESIPRAMINE | 1 | U | 0 | |||||||||||
| 127061302 | 12706130 | 19 | C | TRIAZOLAM. | TRIAZOLAM | 1 | U | 0 | |||||||||||
| 127061302 | 12706130 | 20 | C | MULTAQ | DRONEDARONE | 1 | U | 0 | |||||||||||
| 127061302 | 12706130 | 21 | C | BENICAR | OLMESARTAN MEDOXOMIL | 1 | U | 0 | |||||||||||
| 127061302 | 12706130 | 22 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 127061302 | 12706130 | 23 | C | FUROSEMIDE. | FUROSEMIDE | 1 | U | 0 | |||||||||||
| 127061302 | 12706130 | 24 | C | VIAGRA | SILDENAFIL CITRATE | 1 | U | 0 | |||||||||||
| 127061302 | 12706130 | 25 | C | VITAMIN B COMPLEX | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | U | 0 | |||||||||||
| 127061302 | 12706130 | 26 | C | BRINTELLIX | VORTIOXETINE HYDROBROMIDE | 1 | U | 0 | |||||||||||
| 127061302 | 12706130 | 27 | C | CLARITIN | LORATADINE | 1 | U | 0 | |||||||||||
| 127061302 | 12706130 | 28 | C | COREG | CARVEDILOL | 1 | U | 0 | |||||||||||
| 127061302 | 12706130 | 29 | C | FLAXSEED | FLAX SEED | 1 | U | 0 | |||||||||||
| 127061302 | 12706130 | 30 | C | GABAPENTIN. | GABAPENTIN | 1 | U | 0 | |||||||||||
| 127061302 | 12706130 | 31 | C | IBUPROFEN. | IBUPROFEN | 1 | U | 0 | |||||||||||
| 127061302 | 12706130 | 32 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | U | 0 | |||||||||||
| 127061302 | 12706130 | 33 | C | Multivitamin | VITAMINS | 1 | U | 0 | |||||||||||
| 127061302 | 12706130 | 34 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | U | 0 | |||||||||||
| 127061302 | 12706130 | 35 | C | TYLENOL | ACETAMINOPHEN | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127061302 | 12706130 | 1 | Fibromyalgia |
| 127061302 | 12706130 | 4 | Blood cholesterol increased |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127061302 | 12706130 | Pain in extremity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127061302 | 12706130 | 1 | 201008 | 201012 | 0 | |
| 127061302 | 12706130 | 3 | 201603 | 0 | ||
| 127061302 | 12706130 | 4 | 201602 | 0 |